Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types

Wu, YL; Huang, W; Xie, YT; Wang, CY; Luo, N; Chen, YY; Wang, LF; Cheng, ZP; Gao, ZL; Liu, SP

Cheng, ZP; Liu, SP (通讯作者)，Tongji Univ, Shanghai Peoples Hosp 10, Dept Obstet & Gynecol, Shanghai, Peoples R China.;Gao, ZL (通讯作者)，Tongji Univ Sch Med, Yangzhi Rehabil Hosp, Shanghai Sunshine Rehabil Ctr, Shanghai, Peoples R China.;Cheng, ZP (通讯作者)，Tongji Univ Sch Med, Gynecol Minimally Invas Surg Res Ctr, Shanghai, Peoples R China.;Gao, ZL (通讯作者)，Xinyang Vocat & Tech Coll, Xinyang, Peoples R China.;Gao, ZL (通讯作者)，Shanghai Univ, Affiliated Nantong Hosp Shanghai Univ, Peoples Hosp Nantong 6, Sch M

FRONTIERS IN MOLECULAR BIOSCIENCES, 2022; 9 ():

Abstract

Siglec-9, a cell surface transmembrane receptor mainly expressed on B cells, CD56(+) NK cells, and CD4(+) and CD8(+) T cells, is strongly related to t......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索